Curative, Inc. is a healthcare startup company best known for scaling COVID-19 testing and COVID-19 vaccinations during the COVID-19 pandemic. Headquartered in San Dimas, California, and operating throughout the United States, the company was founded in January 2020 by Fred Turner, Isaac Turner (no relation), and Vlad Slepnev to create new diagnostic tests for sepsis and to improve outcomes for sepsis patients. In response to an urgent, unmet need for COVID-19 test development and production in the United States, Curative rapidly shifted focus in March 2020. The company's research team developed a new test for SARS-CoV-2 that utilized oral swabs rather than nasopharyngeal swabs. The Curative test was designed with a scalable process and opportunities to reduce healthcare worker exposure risk and the amount of personal protective equipment (PPE) used. An independent manufacturing and supply chain model was adopted to avoid competing with existing COVID-19 test companies for limited supplies and laboratory capacity.